Melrose Industries PLC Director/PDMR Shareholding

RNS Number : 2287O

Melrose Industries PLC

13 May 2024

 

13 May 2024

Melrose Industries PLC (the "Company")

Notification of Transactions of Persons Discharging Managerial Responsibility in accordance with Article 19(1) of the Market Abuse Regulation (2014/596/EU) ("MAR")

The Company announces that it was informed that Justin Dowley, Non-executive Chairman, bought 2,950 Ordinary Shares of 160/7 pence each in the Company, in accordance with the terms of the Melrose Dividend Reinvestment Plan. These shares were purchased today at a price of 597.83 pence per share. Following this transaction, Mr Dowley now holds an interest of 517,073 Ordinary Shares in the Company, representing approximately 0.040% of the issued share capital of the Company (excluding treasury shares).

Enquiries:

Montfort Communications:	[phone]
Nick Miles, Charlotte McMullen	[phone] / [phone]

Notification of Transactions of Persons Discharging Managerial Responsibility in accordance with Article 19(1) of MAR

1.	Details of PDMR / person closely associated with them ("PCA")
a)	Name of natural person	Justin Dowley
2.	Reason for the notification
a)	Position / status	Non-executive Chairman
b)	Initial notification / amendment	Initial Notification
3.	Details of the issuer
a)	Full name of the entity	Melrose Industries PLC
b)	Legal Entity Identifier code	213800RGNXXZY2M7TR85
4.	Details of the transaction(s)
a)	Description of the financial instrument, type of instrument	Ordinary shares of 160/7 pence each
b)	Identification Code	GB00BNGDN821
c)	Nature of the transaction	Purchase of ordinary shares of the issuer in accordance with the terms of the Melrose Dividend Reinvestment Plan
d)	Currency	GBP - British Pound
e)	Price(s) and volume(s)	Price Volume GBP  5.9783 2,950
f)	Aggregated information   - Aggregated volume   - Price	2,950   GBP 17,635.99
g)	Date of the transaction	13 May 2024
h)	Place of the transaction	London Stock Exchange

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

DSHFLFFSEVIVLIS